CCM

Catalio Capital Management Portfolio holdings

AUM $566M
1-Year Est. Return 106.72%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+106.72%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$566M
AUM Growth
+$24.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
52
New
Increased
Reduced
Closed

Top Buys

1
+$35.2M
2
+$31.2M
3
+$23.9M
4
EW icon
Edwards Lifesciences
EW
+$15.4M
5
MLYS icon
Mineralys Therapeutics
MLYS
+$13.3M

Top Sells

1
+$35.9M
2
+$32.3M
3
+$30.1M
4
ISRG icon
Intuitive Surgical
ISRG
+$23.5M
5
NTRA icon
Natera
NTRA
+$18M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IRON icon
26
Disc Medicine
IRON
$2.3B
$8.77M 1.55%
110,427
-106,100
OCUL icon
27
Ocular Therapeutix
OCUL
$2.25B
$8.67M 1.53%
+714,501
SEPN
28
Septerna Inc
SEPN
$1.23B
$8.21M 1.45%
294,360
TARA icon
29
Protara Therapeutics
TARA
$312M
$7.71M 1.36%
1,446,254
-54,539
QURE icon
30
uniQure
QURE
$663M
$6.9M 1.22%
288,345
+5,405
OLMA icon
31
Olema Pharmaceuticals
OLMA
$1.81B
$6.68M 1.18%
+267,058
TERN icon
32
Terns Pharmaceuticals
TERN
$4.57B
$5.53M 0.98%
+136,958
RARE icon
33
Ultragenyx Pharmaceutical
RARE
$2.07B
$3.74M 0.66%
162,550
-128,712
HTFL
34
Heartflow Inc
HTFL
$2.12B
$3.32M 0.59%
+113,857
GRAL
35
GRAIL Inc
GRAL
$2.09B
$2.59M 0.46%
30,313
-107,615
FULC icon
36
Fulcrum Therapeutics
FULC
$543M
$2.28M 0.4%
+201,301
BLLN
37
BillionToOne Inc
BLLN
$3.3B
$2.09M 0.37%
+25,505
ELDN icon
38
Eledon Pharmaceuticals
ELDN
$209M
$1.9M 0.34%
1,259,820
+198,688
HYPR icon
39
Hyperfine
HYPR
$106M
$1.29M 0.23%
1,320,041
+635,500
PVLA
40
Palvella Therapeutics
PVLA
$1.6B
$1.09M 0.19%
10,452
-1,558
KPTI icon
41
Karyopharm Therapeutics
KPTI
$162M
$1.05M 0.19%
142,984
MGX icon
42
Metagenomi Therapeutics
MGX
$60.5M
$857K 0.15%
528,993
ATAI icon
43
AtaiBeckley Inc
ATAI
$1.29B
$805K 0.14%
196,858
OM icon
44
Outset Medical
OM
$62.9M
$439K 0.08%
118,279
SNSE icon
45
Sensei Biotherapeutics
SNSE
$38.5M
$157K 0.03%
14,718
ABBV icon
46
AbbVie
ABBV
$411B
– –
-154,834
BBIO icon
47
BridgeBio Pharma
BBIO
$12.8B
– –
-622,729
CDTX
48
DELISTED
Cidara Therapeutics
CDTX
– –
-53,333
EXAS icon
49
Exact Sciences
EXAS
$19.7B
– –
-248,987
MLTX icon
50
MoonLake Immunotherapeutics
MLTX
$1.29B
– –
-133,131
1
2
3